Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 10

1.

Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention.

Zhang H, Zhang A, Kohan DE, Nelson RD, Gonzalez FJ, Yang T.

Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9406-11. Epub 2005 Jun 14.

PMID:
15956187
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Cardiovascular implications of thiazolidinedione therapy.

Lamb RE, King D.

Prog Cardiovasc Nurs. 2004 Summer;19(3):116-22. Review.

PMID:
15249773
[PubMed - indexed for MEDLINE]
3.

Thiazolidinedione-induced congestive heart failure.

Cheng AY, Fantus IG.

Ann Pharmacother. 2004 May;38(5):817-20. Epub 2004 Mar 23.

PMID:
15039476
[PubMed - indexed for MEDLINE]
4.

Considerations for management of fluid dynamic issues associated with thiazolidinediones.

Hollenberg NK.

Am J Med. 2003 Dec 8;115 Suppl 8A:111S-115S. Review.

PMID:
14678876
[PubMed - indexed for MEDLINE]
5.

The patient with diabetes mellitus and heart failure: at-risk issues.

Giles TD.

Am J Med. 2003 Dec 8;115 Suppl 8A:107S-110S. Review.

PMID:
14678875
[PubMed - indexed for MEDLINE]
6.

Thiazolidinediones, peripheral edema, and type 2 diabetes: incidence, pathophysiology, and clinical implications.

Mudaliar S, Chang AR, Henry RR.

Endocr Pract. 2003 Sep-Oct;9(5):406-16. Review.

PMID:
14583425
[PubMed - indexed for MEDLINE]
7.

[Thiazolidinediones in type 2 diabetes. Role of peroxisome proliferator-activated receptor gamma (PPARgamma)].

Dubois M, Vantyghem MC, Schoonjans K, Pattou F.

Ann Endocrinol (Paris). 2002 Dec;63(6 Pt 1):511-23. Review. French.

PMID:
12527853
[PubMed - indexed for MEDLINE]
8.

Combination of insulin and thiazolidinedione therapy in massively obese patients with Type 2 diabetes.

Buch HN, Baskar V, Barton DM, Kamalakannan D, Akarca C, Singh BM.

Diabet Med. 2002 Jul;19(7):572-4.

PMID:
12099960
[PubMed - indexed for MEDLINE]
9.

Metabolic and additional vascular effects of thiazolidinediones.

Martens FM, Visseren FL, Lemay J, de Koning EJ, Rabelink TJ.

Drugs. 2002;62(10):1463-80. Review.

PMID:
12093315
[PubMed - indexed for MEDLINE]
10.

Rosiglitazone: an agent from the thiazolidinedione class for the treatment of type 2 diabetes.

Cheng-Lai A, Levine A.

Heart Dis. 2000 Jul-Aug;2(4):326-33. Review.

PMID:
11728276
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk